Condition or disease | Intervention/treatment |
---|---|
Barlow's Disease Prolapse; Mitral | Procedure: Right minithoracotomy Procedure: Sternotomy |
Study Type : | Observational |
Actual Enrollment : | 208 participants |
Observational Model: | Case-Only |
Time Perspective: | Retrospective |
Official Title: | Minimally Invasive or Conventional Edge-To-Edge Repair for Severe Mitral Regurgitation Due to Bileaflet Prolapse in Barlow's Disease: Does the Surgical Approach Have an Impact on the Long-term Results? |
Actual Study Start Date : | December 1, 2016 |
Actual Primary Completion Date : | December 1, 2016 |
Actual Study Completion Date : | December 1, 2016 |
Group/Cohort | Intervention/treatment |
---|---|
MT-Right |
Procedure: Right minithoracotomy
Incision of the right chest between 3rd and 4th or 4th and 5th intercostal space
|
Sternotomy |
Procedure: Sternotomy
Longitudinal resection of the sternum
|
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Patients with severe MR due to the prolapse of both leaflets in the context of Barlow's disease submitted to EE repair via a video-assisted right minithoracotomy (minithoracotomy group) and patients with Barlow's disease treated with surgical mitral repair with the EE technique through a conventional median sternotomy (sternotomy group).
The diagnosis of Barlow's disease was made during a preoperative transoesophageal echocardiographic (TEE) examination and confirmed by the surgeon's direct assessment of the valve. All patients had excessive leaflet tissue, annular dilatation and bileaflet prolapse. Cases with a forme fruste of Barlow's disease were excluded.
Inclusion Criteria:
Patients treated for bileaflet prolapse in Barlow's Disease between 1997 and 2011
Exclusion Criteria:
Age inferior to 18 years
No Contacts or Locations Provided
Tracking Information | |||||
---|---|---|---|---|---|
First Submitted Date | June 27, 2019 | ||||
First Posted Date | June 28, 2019 | ||||
Results First Submitted Date | February 6, 2020 | ||||
Results First Posted Date | February 19, 2020 | ||||
Last Update Posted Date | August 7, 2020 | ||||
Actual Study Start Date | December 1, 2016 | ||||
Actual Primary Completion Date | December 1, 2016 (Final data collection date for primary outcome measure) | ||||
Current Primary Outcome Measures |
|
||||
Original Primary Outcome Measures |
|
||||
Change History | |||||
Current Secondary Outcome Measures | Not Provided | ||||
Original Secondary Outcome Measures | Not Provided | ||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||
Descriptive Information | |||||
Brief Title | Minimally Invasive or Conventional Edge-To-Edge Repair for Severe Mitral Regurgitation Due to Bileaflet Prolapse in Barlow's Disease: Does the Surgical Approach Have an Impact on the Long-term Results? | ||||
Official Title | Minimally Invasive or Conventional Edge-To-Edge Repair for Severe Mitral Regurgitation Due to Bileaflet Prolapse in Barlow's Disease: Does the Surgical Approach Have an Impact on the Long-term Results? | ||||
Brief Summary | The study evaluates the long-term results of patients affected by bileaflet prolapse in Barlow's Disease, treated with edge-to-edge technique between 1997 and 2011. | ||||
Detailed Description | Not Provided | ||||
Study Type | Observational | ||||
Study Design | Observational Model: Case-Only Time Perspective: Retrospective |
||||
Target Follow-Up Duration | Not Provided | ||||
Biospecimen | Not Provided | ||||
Sampling Method | Non-Probability Sample | ||||
Study Population |
Patients with severe MR due to the prolapse of both leaflets in the context of Barlow's disease submitted to EE repair via a video-assisted right minithoracotomy (minithoracotomy group) and patients with Barlow's disease treated with surgical mitral repair with the EE technique through a conventional median sternotomy (sternotomy group). The diagnosis of Barlow's disease was made during a preoperative transoesophageal echocardiographic (TEE) examination and confirmed by the surgeon's direct assessment of the valve. All patients had excessive leaflet tissue, annular dilatation and bileaflet prolapse. Cases with a forme fruste of Barlow's disease were excluded. |
||||
Condition |
|
||||
Intervention |
|
||||
Study Groups/Cohorts |
|
||||
Publications * | Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Lung B, Lancellotti P, Pierard L, Price S, Schäfers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M; ESC Committee for Practice Guidelines (CPG); Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS). Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2012 Oct;42(4):S1-44. doi: 10.1093/ejcts/ezs455. Epub 2012 Aug 25. | ||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status | Completed | ||||
Actual Enrollment |
208 | ||||
Original Actual Enrollment | Same as current | ||||
Actual Study Completion Date | December 1, 2016 | ||||
Actual Primary Completion Date | December 1, 2016 (Final data collection date for primary outcome measure) | ||||
Eligibility Criteria |
Inclusion Criteria: Patients treated for bileaflet prolapse in Barlow's Disease between 1997 and 2011 Exclusion Criteria: Age inferior to 18 years |
||||
Sex/Gender |
|
||||
Ages | 18 Years and older (Adult, Older Adult) | ||||
Accepts Healthy Volunteers | No | ||||
Contacts | Contact information is only displayed when the study is recruiting subjects | ||||
Listed Location Countries | Not Provided | ||||
Removed Location Countries | |||||
Administrative Information | |||||
NCT Number | NCT04002648 | ||||
Other Study ID Numbers | MICETE-BBL | ||||
Has Data Monitoring Committee | No | ||||
U.S. FDA-regulated Product |
|
||||
IPD Sharing Statement |
|
||||
Responsible Party | Michele De Bonis, Ospedale San Raffaele | ||||
Study Sponsor | Ospedale San Raffaele | ||||
Collaborators | Not Provided | ||||
Investigators | Not Provided | ||||
PRS Account | Ospedale San Raffaele | ||||
Verification Date | July 2020 |